These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 14440267)
1. Effect of MER-29 (triparanol) on serum cholesterol, cholesterol esters and liver enzymes. RUSKIN A; RUSKIN B Prog Cardiovasc Dis; 1960 May; 2():624-30. PubMed ID: 14440267 [No Abstract] [Full Text] [Related]
2. Observations on the effect of triparanol (MER-29) on the serum cholesterol of selected human subjects. ROSENMAN RH; FRIEDMAN M Prog Cardiovasc Dis; 1960 May; 2():605-11. PubMed ID: 14439028 [No Abstract] [Full Text] [Related]
3. Effect of MER-29 on serum cholesterol and blood clotting mechanisms: a plan of study and preliminary findings. II. TODD ME Prog Cardiovasc Dis; 1960 May; 2():555-62. PubMed ID: 13838620 [No Abstract] [Full Text] [Related]
4. Studies of serum desmosterol levels in hypercholesteremic subjects treated with triparanol (MER-29). Sachs BA; Wolfman L Am J Clin Nutr; 1961; 9():760-3. PubMed ID: 14495832 [No Abstract] [Full Text] [Related]
5. A brief experience with triparanol (MER-29). STRAIGHT WM; LAHUIS NC J Fla Med Assoc; 1961 Oct; 48():341-5. PubMed ID: 13917595 [No Abstract] [Full Text] [Related]
6. The effects of triparanol (MER-29) in subjects with and without coronary artery disease. HOLLANDER W; CHOBANIAN AV; WILKINS RW JAMA; 1960 Sep; 174():5-12. PubMed ID: 13852511 [No Abstract] [Full Text] [Related]
7. The use of triparanol to lower serum cholesterol. GOYETTE EM; ELDER JC Am Heart J; 1960 Oct; 60():536-8. PubMed ID: 13707585 [No Abstract] [Full Text] [Related]
8. The treatment of hypercholesterolemia by interference with cholesterol biosynthesis using MER-29. LECKERT JT; MCHARDY G; MCHARDY R; WELCH GE; CRADIC H J La State Med Soc; 1960 Jul; 112():259-65. PubMed ID: 14415072 [No Abstract] [Full Text] [Related]
9. Effects of triparanol on serum low-density lipoproteins and cholesterol. ENGELBERG H Geriatrics; 1962 Aug; 17():528-31. PubMed ID: 13890232 [No Abstract] [Full Text] [Related]
10. Clinical evaluation of MER-29 in the treatment of hypercholesterolemia associated with atherosclerosis. LECKERT JT; MCHARDY GG; MCHARDY RJ; WELCH GE; CRADIC H Prog Cardiovasc Dis; 1960 May; 2():571-5. PubMed ID: 14415073 [No Abstract] [Full Text] [Related]
11. [Action of triparanol on blood lipid changes]. MARCHESE G G Gerontol; 1962 May; 10():449-61. PubMed ID: 14469633 [No Abstract] [Full Text] [Related]
12. The effect of MER-29, a cholesterol synthesis inhibitor, on adrenal function, blood clotting mechanisms, and serum lipids, before and after simulated stress in man. FORD RV Prog Cardiovasc Dis; 1960 May; 2():548-52. PubMed ID: 13823923 [No Abstract] [Full Text] [Related]
13. HYPOCHOLESTEREMIC AGENTS. 3. BASIC CARBINOLS AND RELATED COMPOUNDS. SHORT JH; BIERMACHER U; DUNNIGAN DA; LAMBERT GF; MARTIN DL; NORDEEN CW; WRIGHT HB J Med Chem; 1965 Mar; 8():223-30. PubMed ID: 14332666 [No Abstract] [Full Text] [Related]
14. HYPOCHOLESTEREMIC AGENTS. I. PYRIDYL CARBINOLS. WRIGHT HB; DUNNIGAN DA; BIERMACHER U J Med Chem; 1964 Jan; 7():113-5. PubMed ID: 14186010 [No Abstract] [Full Text] [Related]
15. A CORRELATION OF DRUG CONCENTRATION WITH STEROL BIOSYNTHESIS INHIBITION IN THE LIVER. FIGDOR SK; SCHREIBER EC; STEBBINS RB; MOORE PF; PINSON R J Med Chem; 1964 Jul; 7():508-10. PubMed ID: 14221136 [No Abstract] [Full Text] [Related]
16. Effect of triparanol (MER/29) on corticosterone secretion by rat adrenals. HOLLOSZY J; EISENSTEIN AB Proc Soc Exp Biol Med; 1961 Jun; 107():347-9. PubMed ID: 13715399 [No Abstract] [Full Text] [Related]
17. The hypocholesterolemic effect of triparanol (MER-29) in man. RUSKIN A Arch Intern Med; 1960 Dec; 106():803-8. PubMed ID: 13744810 [No Abstract] [Full Text] [Related]
18. Effects of MER-29 on the intermediary metabolism of cholesterol. FRANTZ ID; MOBBERLEY ML; SCHROEPFER GJ Prog Cardiovasc Dis; 1960 May; 2():511-8. PubMed ID: 13824600 [No Abstract] [Full Text] [Related]
19. Identification of 24-dehydrocholesterol in the serum of patients treated with MER-29. STEINBERG D; AVIGAN J; FEIGELSON EB Prog Cardiovasc Dis; 1960 May; 2():586-92. PubMed ID: 13834161 [No Abstract] [Full Text] [Related]
20. [Clinical trials in atherosclerotics with Triparanol (MER-29) diminishing the biosynthesis of cholesterol]. KELLER L; GERGELY J Z Gesamte Inn Med; 1962 Feb; 17():183-6. PubMed ID: 14454950 [No Abstract] [Full Text] [Related] [Next] [New Search]